Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
Age and molecular subtypes: impact on surgical decisions.
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
Is there a low-grade precursor pathway in breast cancer?
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer.
Impact of breast density on the presenting features of malignancy.
Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors.
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Age, molecular subtypes and local therapy decision-making.
Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.
Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come.
Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach.